⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Threonic Acid SCHEMBL6437643 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL16609889 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL925622 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL27279909 | 1.00 | PDE4A (0.67) | — | |
| L-Threonic Acid SCHEMBL18614891 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL120198 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL29007322 | 0.97 | PDE4A (0.64) | — | |
| L-Threonic Acid SCHEMBL8684453 | 0.97 | PDE4A (0.64) | — | |
| L-Threonic Acid SCHEMBL29945675 | 0.97 | PDE4A (0.64) | — | |
| L-Threonic Acid SCHEMBL29945694 | 0.97 | PDE4A (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2406 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031581-A | Composition for preventing, treating and/or relieving hyperuricemia and application thereof | 广西医科大学 | 2026-05-15 | — | — | CN | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2026-03-03 | — | — | US | claimed |
| US-20260049990-A1 | BIOMARKER FOR DIAGNOSING IMMUNE-RELATED DISEASES USING ASPARTATE METABOLITE | SUNGKWANG MEDICAL FOUNDATION (KR) | 2026-02-19 | — | — | US | claimed |
| EP-4683640-A1 | NOVEL PHOSPHATE COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | Samant, Rajaram (IN) | 2026-01-28 | — | — | EP | claimed |
| EP-4682260-A1 | ANTIMICROBIAL LACTOBACILLUS FERMENT | Symrise AG (DE) | 2026-01-21 | — | — | EP | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| WO-2025263641-A1 | COMPOSITION COMPRISING GLYCOLIPID, CATIONIC POLYMER AND (POLY)HYDROXY ACID | L'OREAL (FR) | 2025-12-26 | — | — | WO | claimed |
| EP-4649314-A2 | POLYOL SWEETENERS AND CARDIOVASCULAR AND THROMBOTIC EVENT RISK | The Cleveland Clinic Foundation (US) | 2025-11-19 | — | — | EP | claimed |
| US-5554654-A | COMPRISING SALICYLIC ACID, RETINOIC ACID, ERYTHROMYCIN, METRONIDAZOLE, TETRACYCLINE, CLINDAMYCIN, MINOCYCLINE, MECLOCYCLINE OR BENZILIC ACID BY COMBINING WITH 2-HYDROXY ACID, 2-KETOACID, DERIVATIVE THEREOF OR RELATED COMPOUND | TRISTRATA INC (US) | 1996-09-10 | — | — | US | claimed |
| EP-0681481-A1 | HIGHLY SOLUBLE MULTICOMPONENT INCLUSION COMPLEXES CONTAINING A BASE TYPE DRUG, AN ACID AND A CYCLODEXTRIN | CHIESI FARMACEUTICI S.p.A. (IT) | 1995-11-15 | — | — | EP | claimed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | claimed |
| WO-1994016733-A1 | HIGHLY SOLUBLE MULTICOMPONENT INCLUSION COMPLEXES CONTAINING A BASE TYPE DRUG, AN ACID AND A CYCLODEXTRIN | CHIESI FARMACEUTICI S.P.A. (IT) | 1994-08-04 | — | — | WO | claimed |
| WO-1992018116-A1 | COMPOSITIONS COMPRISING 2-HYDROXYCARBOXYLIC ACIDS AND RELATED COMPOUNDS, AND METHODS FOR ALLEVIATING SIGNS OF DERMATOLOGICAL AGING | YU RUEY J (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0508324-A2 | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | Yu, Ruey J., Dr. (US) | 1992-10-14 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| US-4936958-A | Process for production of enantiomerically pure 2,2,4-trisubstituted 1,3-dioxolanes | LONZA LTD. (CH) | 1990-06-26 | — | — | US | claimed |
| US-4306979-A | Foam type fire extinguishing agent for hydrophilic combustible liquids | HOCHIKI CORPORATION (JP) | 1981-12-22 | — | — | US | claimed |